Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception

Human Pathology

Volumn 29, Issue 2, 1998, Pages 170-174

  Hermonat, Paul L ^a,b   Kechelava, Sofia ^a   Lowery, Curtis L ^a   Korourian, Soheila ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Human papillomavirus; In situ polymerase chain reaction; Spontaneous abortion

Indexed keywords

ARTICLE; HUMAN; HUMAN TISSUE; PLACENTA; POLYMERASE CHAIN REACTION; PREVALENCE; SPONTANEOUS ABORTION; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; TROPHOBLASTIC DISEASE; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0031887445     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90228-3     Document Type: Article

References (30)

1. Brown ZA, Vontver LA, Benedetti J, et al: Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 317:1246-1251, 1987
2. Monif GR; Maternal mumps infections during gestation: Observations in the progeny. Am J Obstet Gynecol 119:549-551, 1974
3. Miller E, Cradock-Watson JE, Pollock TM: Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2:781-784, 1982
4. Peckham C: Congenital rubella in the United Kingdom before 1970: The prevaccine era. Rev Infect Dis 7:11S, 1985
5. Stagno S, Pass RF, Dworsky ME, et al: The nature of maternal cytomegalovirus infection and its consequences for the infant, in Ennis FA (ed): Human Immunity to Viruses. New York, NY, Academic Press, 1983, pp 219-239
6. Icart J, Didier J, Dalens M, et al: Prospective study of EBV infection during pregnancy. Biomedicine 34:160-163, 1981
7. Hermonat PL, Han L, Wendel P, et al: Human papillomavirus DNA is more prevalent in first trimester spontaneously aborted products of conception compared to elected specimens. Virus Genes 14:13-17, 1977
8. Mergui JL, De Brux J, Salat-Baroux J: Incidence et evolution des condylomes cervicaux au cour de la grossesse. J Gynecol Obstet Biol Reprod (Paris) 12:651-656, 1984
9. Fife KH, Rogers RE, Zwickl BW: Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy. J Infect Dis 156:904-911, 1987
10. Schneider A, Hotz M, Gissmann L: Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 40:198-201, 1987
11. Rando RF, Lindheim S, Hasty L, et al: Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 161:50-55, 1989
12. Gloss B, Bernard H-U, Seedorf K, et al: The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 6:3735-3743, 1987
13. Mittal R, Tsutsumi K, Pater A, et al: Human papillomavirus type 16 expression in cervical keratinocytes: Role of progesterone and glucocorticoid hormones. Obstet Gynecol 81:5-12, 1993
14. von Knebel-Doeberitz M, Bauknecht T, Bartsch D, et al: Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A 88:141-1415, 1991
15. Weinberg ED: Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6:814-831, 1984
16. Wegmann TG, Lin H, Guilbert L, et al: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 14:353-356, 1993
17. Seedorf K, Krammer G, Durst M, et al: Human papillomavirus type 16 DNA sequence. Virology 145:181-185, 1985
18. Baker CC, Phelps WC, Lindgren V, et al: Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962-971, 1987
19. Clark DA, Banwatt D, Croy BA: Murine trophoblast failure and spontaneous abortion. Am J Reprod Immunol 29:199-205, 1993
20. Hill JA: T-helper 1-type immunity to trophoblast: Evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod 10:114-120, 1995
21. Rodriguez JL, Brooks DL, Damassa AJ, et al: 1996 Immunohistochemical and ultrastructural characteristics of mycoplasma capricolum subsp. capricolum in caprine abortion: A case study. Theriogenology 16:379-385, 1996
22. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79, 1990
23. Scheffner M, Werness BA, Huibregtse JM, et al: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990
24. Dyson N, Howley PM, Munger K, et al: The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243;934-937, 1989
25. Munger E, Werness BA, Dyson N, et al: Complex formation of human papillomavirus E7 with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099-5105, 1989
26. Casey G, LoHsueh M, Lopez ME, et al: Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 6:1791-1797, 1991
27. Madreperrla SA, Whittum-Hudson JA, Prendergast RA, et al. Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells. Cancer Res 51:6381-6384, 1991
28. Gallego MI, Lazo PA: Deletion in human chromosome region 12q13-15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J Biol Chem 270:24321-24326, 1995
29. Tobiasch E, Rabreau M, Geletneky K, et al: Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol 44:215-222, 1994
30. Lai YM, Yang FP, Pao CC: Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells. Fertil Steril 65:1026-1030, 1996